CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved.

UBS and Barclays upgrade Royal Bank of Scotland ahead of Q1 results

Analysts at UBS and Barclays Capital upgrade Royal Bank of Scotland ahead of its first quarter results on Friday.

Analysts at UBS and Barclays Capital upgraded Royal Bank of Scotland (RBS) ahead of its first quarter (Q1) results on Friday 1 May.

UBS raised its rating for RBS to a ‘buy’ rating, while analysts from Barclays Capital upped their assessment of the stock to ‘underweight’. However, the pair both downgraded their target price for RBS to 150p and 130p, respectively.

Based on RBS trading at 114p per share as of 12:45 (GMT) on Wednesday, analysts from both banks believe the stock has a potential upside of between 14% - 31%.

UK banks likely hit by bad loan losses

Investors are expecting RBS and other UK banks to be hit hard by bad loans, damaging their respective capital positions amid the Covid-19 crisis.

Acting proactively, the Bank of England (BoE) has urged RBS and other UK lenders to be lenient on borrowers and show restraint in booking charges for bad debts in a bid to shore up their balance sheets.

Across the Atlantic, the top six largest US banks have allocated over $25 billion in total for the first quarter in preparation of major losses as a consequence of the economic fallout from the viral pandemic.

As a result, the BoE is concerned that UK banks will take similar action which would significantly hinder their ability to lend to businesses in desperate need of cash.

Investors are eagerly awaiting RBS and other UK banks earnings to see just how much the coronavirus outbreak has impacted their financial performance and their ability to support the wider economy.

PRA requests UK banks suspend dividend

Much to the disappointment of shareholders, Britain’s largest lenders complied with guidance from the Bank of England (BoE) and suspended dividend pay-outs in 2020.

Barclays, Lloyds, RBS, HSBC, Santander and Standard Chartered all said that they would cancel their dividends for the 2019 financial year and agreed to refrain from making any pay-outs to shareholders in 2020. The banks even promised to cancel any share buyback initiatives too.

The Prudential Regulation Authority (PRA), the supervisory division of the BoE, welcomed the dividend cancellations and not having to take any formal action against any UK banks.

The PRA hopes that by keeping cash on lenders balance sheets, rather than in shareholders pockets, it will help the industry offset some of the impact of the Covid-19 crisis.

The regulator also expects banks not to pay any cash bonuses to senior staff over the coming months.

How much does it cost to buy UK shares with IG?

There are three ways to ‘buy’ UK shares with IG: trading CFDs or buying physical shares. The cost will depend on which method you choose. The table below illustrates how the costs to get exposure to £10,000 of Lloyds stock, which is equivalent to 16,000 shares (quoted at 62.5p a share).

Remember, CFDs are derivatives, which come with higher risk and reward than investing.

Cost to get exposure to Lloyds stock

CFD trading Share trading
Action Buy 16,000 share CFDs Buy 16,000 shares
Capital required to open £2000 £10,000
Total fees £20.88 £16

Ready to start trading shares? Open a live account or practise on a demo.


The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer.

Act on share opportunities today

Go long or short on thousands of international stocks with CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take your position.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.